title: Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood.
abstract: BACKGROUND
  The immunosuppressants cyclosporine and FK506 have been used successfully in clinical transplantation, but both agents have various side effects. We have previously found that cyclosporine is prothrombotic and that FK506 is antithrombotic in an in vivo system. The aim of the present study was to assess the effects of these agents on platelet reactivity and coagulation using an in vitro shear-induced hemostatic platelet plug-forming instrument, the hemostatometer.
  
  
  METHODS
  A purpose-built hemostatometer was constructed in our laboratory. The effects of cyclosporine and FK506 on platelet reactivity and coagulation were assessed under high shear stress using non-anticoagulated rat and human blood.
  
  
  RESULTS
  FK506 significantly inhibited both platelet reactivity and coagulation. Cyclosporine also significantly inhibited coagulation, but a proaggregatory effect was observed at a final blood concentration of 0.05 mg/ml.
  
  
  CONCLUSIONS
  The present in vitro results support our previous in vivo findings regarding the prothrombotic and antithrombotic effects of cyclosporine and FK506, respectively.
authors.affiliation: Faculty of Nutrition, Kobe Gakuin University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Muraki
authors.forename: T
authors.initials: T
authors.lastname: Taka
authors.forename: T
authors.initials: T
authors.lastname: Noguchi
authors.forename: H
authors.initials: H
authors.lastname: Ishii
authors.forename: J
authors.initials: J
authors.lastname: Seki
authors.forename: J
authors.initials: J
authors.lastname: Yamamoto
mesh_terms: D000328:Adult; D000818:Animals; D000925:Anticoagulants; D001777:Blood Coagulation / Q000187:drug effects / Q000276:immunology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D016572:Cyclosporine / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013314:Stress, Mechanical; D016559:Tacrolimus / Q000494:pharmacology*
chemical_list: D000925:Anticoagulants; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D016572:Cyclosporine; D016559:Tacrolimus